INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 30 November 2012
Total net assets |
£131.3m |
NAV per share |
236.7p |
Share price |
196.3p |
Total value of unquoted investments |
£22.2m |
Total number of portfolio companies |
65 |
Cash |
7% NAV |
Cash committed and reserved to unquoted investments |
(5)% NAV |
Portfolio companies with < 1 year of cash |
18.04% NAV |
Top Ten Holdings
Company Name |
% NAV |
Amgen Celgene Gilead |
7.7 7.1 4.5 |
Aptiv |
4.3 |
Alexion |
3.7 |
Pharmaxis |
3.2 |
Onyx |
3.0 |
Insulet |
2.9 |
Actelion Jazz |
2.7 2.6 |
|
----------- |
Total |
41.7 |
Geographical Allocation |
% |
United States & Canada |
80 |
Europe |
10 |
Australia |
3 |
Cash |
7 |
|
----------- |
Total |
100 |
Quoted/Unquoted allocation |
% |
Quoted |
76 |
Unquoted |
17 |
Cash |
7 |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
19 DECEMBER 2012